Maven Securities LTD Syndax Pharmaceuticals Inc Transaction History

Maven Securities LTD

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$14.84 - $22.15 $349,170 - $521,167
-23,529 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$15.23 - $22.47 $358,346 - $528,696
23,529 New
23,529 $515,000
Q1 2021

May 17, 2021
SELL
$19.28 - $24.59 $2.89 Million - $3.69 Million
-150,000 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$15.1 - $26.44 $2.27 Million - $3.97 Million
150,000 New
150,000 $3.43 Million

Others Institutions Holding SNDX

# of Institutions
228
Shares Held
88.4M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $740M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email